HIV Awal (Early) Testing & Treatment Indonesia Project Intervention Phase
1 other identifier
interventional
827
1 country
4
Brief Summary
This study will be one of the first to systematically evaluate strategies to improve the implementation of a T\&T strategy in a concentrated epidemic in Asia. HATI Project is an implementation research designed, of which consisted of phase I as observation of available standard practice and data collection and phase II implementation of intervention of intervention designed based on the results of phase I. The first year observation study showed that there are poor cascade of HIV care. The first is the low coverage of HIV test uptake. Along the HIV test and treatment cascade there are substantial reductions. Furthermore, In the qualitative analysis we found several reasons for the study population for not coming to the ARV sites after being diagnosed with HIV, e.g. social and administrative reasons such as not possessing ID card and unsuited hospital opening hours, etc. Another important finding was the requested laboratory testing by the physicians prior to ART initiation, such as Levels of Haemoglobin, serum transaminases, creatinine, and chest X-ray (manuscript in preparation). The aims of the proposed interventions are:
- 1.Increase uptake of HIV testing
- 2.Increase uptake of HIV treatment initiation
- 3.Reduce time from testing to treatment initiation
- 4.Increase percentage of treatment adherence
- 5.Reducing loss to follow-up on ART
- 6.Improve treatment outcomes (virological suppression)
- 7.Oral fluid-based testing (self-testing) as a strategy to overcome barriers of testing
- 8.Simplification of ART initiation
- 9.CBOs and Brothel-based ART service
- 10.SMS reminders to increase treatment adherence
- 11.Motivational Interviewing Approach to increase treatment uptake \& adherence
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 22, 2017
CompletedFirst Submitted
Initial submission to the registry
September 3, 2018
CompletedFirst Posted
Study publicly available on registry
September 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFebruary 5, 2020
February 1, 2020
2.1 years
September 3, 2018
February 4, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of virologically suppressed
Proportion of people from each key population who are virologically suppressed 12 months after HIV diagnosis. Analyses will be conducted separately for each key affected population
12 months
Secondary Outcomes (4)
Quantify and comparing other components of the HIV treatment cascade/continuum of care
12 months
Assess the safety and acceptability of early ART Initiation
12 months
Assess behavioural aspects of Test and Treat Strategy
12 months
Number of participants that virologically suppressed
12 months
Study Arms (6)
Oral Fluid Based Self Testing
EXPERIMENTALAll study participants that received intervention and meet inclusion criteria intervention that will be offered OFT
Control Group
NO INTERVENTIONAll HIV Patients in the clinic that not received any intervention
Simplified ART Initiation
EXPERIMENTALAll study participants that received intervention and meet inclusion criteria intervention that will be offered SAI
CBO AND BROTHEL-BASED ART SERVICE
EXPERIMENTALAll patients coming to brothel or Community Based Organization services will be offered to get tested and received ART
SMS Reminder
EXPERIMENTALAll patients that recently found HIV Positive "HIV Naive" offered to get SMS Reminder
Motivational Interviewing
EXPERIMENTALPWID in Jakarta and Bandung that recently found HIV Positive or lost to follow up ARV offered MI intervention
Interventions
The intervention will introduce provider supervised and unsupervised self-testing as an option for early HIV diagnosis among MSM community in Denpasar Bali Indonesia.
In this intervention, there will be a change in the clinical practice of ART initiation. In the current practice, clients are asked to perform full pre-ART laboratory examination (complete blood count, liver and renal function tests) before decision of ART initiation. In this intervention, the study participants who are already confirmed as HIV positive and meet specific clinical criteria (see below) will initiate ART (antiretroviral therapy) immediately (after clients' approval) without having to perform full pre-ART laboratory examination. Here, laboratory criteria for initiating ART will be simplified and specific laboratory examination, I.e. creatinine test will be delayed in two weeks after ART initiation.
The CBOs involved in this intervention are Kebaya and Vesta. Kebaya is an CBO working for Transgender (TG) community. It serves as community gathering place for TG and others, as HIV testing site on regular bases, and also as shelter for homeless HIV patients. The proposed intervention Is that HATI Project will provide HIV testing and treatment in the community, CBO and brothel in collaboration with nearby Puskesmas.
HATI SMS reminder: short message services as reminders to inform ART patients when to take medication, visit the clinics (1 week before the next visit) and remind if they miss clinic appointment.
The approach used in this intervention is an individual counselling with a MI approach, as it is considered a brief form of therapy have been known to be effective in improving HIV treatment adherence. The sessions will be held from 3 to up to 10 MI counselling over 6-month period of intervention. The goal of this intervention is to help PWID gain an understanding of their medication-taking behaviors and the actions necessary to successfully maintain a high level of adherence
Eligibility Criteria
You may qualify if:
- OFT :
- Refused HTC testing at clinic or outreach setting?
- Aged 18 years and over;
- Not known to be HIV-infected;
- Self-reported anal sex with a man in the last 12 months;
- SAI \& CBO
- WHO clinical stage 1 and 2
- Age \< 50 years old
- Free of Tuberculosis suspicion (based on TB screening form)
- Not suffering from uncontrolled hypertension (blood pressure more than 140 mmHg) and or diabetes (clinical history based on patients interview)
- BMI above 18.5 kg/m2
- ARV naïve
- Well informed and agree to receive ARV
- SMS Reminder :
- Age: ≥ 16 years old
- +8 more criteria
You may not qualify if:
- Known HIV Positive
- Refuse to be included in the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gadjah Mada Universitylead
- Udayana Universitycollaborator
- Hasan Sadikin General Hospitalcollaborator
- Yayasan Kertiprajacollaborator
- World Health Organizationcollaborator
- Sardjito Hospital Yogyakartacollaborator
- Universitas Katholik Atmajayacollaborator
- Universitas Padjadjarancollaborator
- Kirby Institutecollaborator
Study Sites (4)
Yayasan Kerti Praja
Denpasar, Bali, 80223, Indonesia
Dr. Sardjito Hospital, Yogyakarta Indonesia
Yogyakarta, DI Yogyakarta, 55281, Indonesia
Atma Jaya HIV-AIDS Research Centre
Jakarta, DKI Jakarta, 12930, Indonesia
Hasan Sadikin Hospital, Bandung, Indonesia
Bandung, West Java, 40161, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yanri W Subronto, PhD
Gadjah Mada University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD,PhD,Sp.PD-KPTI,FINASIM
Study Record Dates
First Submitted
September 3, 2018
First Posted
September 6, 2018
Study Start
November 22, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
February 5, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share